Jump to main content

博士論文

An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells

Icons representing 博士論文
The cover of this title could differ from library to library.

Available in National Diet Library

Find on the publisher's website

NDL Digital Collections

Digital data available

Check on the publisher's website

DOI[10.1007/s12185-019-02701-2]to the data of the same series

An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells

Persistent ID (NDL)
info:ndljp/pid/11537629
Material type
博士論文
Author
水谷, 優
Publisher
水谷, 優
Publication date
2019
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
神戸大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells
Author/Editor
水谷, 優
Publication, Distribution, etc.
水谷, 優
Publication Date
2019
Publication Date (W3CDTF)
2019
Alternative Title
初代ヒト白血病細胞においてmTORC1/2阻害剤であるAZD2014はリソソーム機能活性化を介してゲムツズマブオゾガマイシンの細胞傷害効果を増強する
Degree grantor/type
神戸大学
Date Granted
2019-09-25
Date Granted (W3CDTF)
2019-09-25